Prevention of Diseases Induced by Chlamydia Trachomatis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1092 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-10

Study Completion Date

2022-11-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of the study is to determine whether early screening and treating young women (\<25 years of age) for genital Chlamydia Trachomatis (Ct) infection reduces the cumulative incidence of pelvic inflammatory disease (PID) over 24 months.

As secondary objectives, the study aims

* To determine the baseline prevalence and the incidence of Ct infection;
* To improve knowledge on natural history of Ct infection in young women such as the rate and timing of progression to PID (at the beginning of the infection, at the end, throughout the course of infection), as well as the incidence of reinfections with Ct;
* To investigate the relation between host immuno-genetic factors and the clearance, persistence and development of late complications (PID) as an explanation for the inter-individual heterogeneity in the susceptibility to and course of Ct infection.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

STD Screening in Women Admitted in Family Planning for a Termination of Pregnancy

NCT03486522

STD

UNKNOWN

Genital CT Treatment to Pregnant Women to Prevent Adverse Pregnancy Outcomes: A Pilot RCT

NCT03862495

Chlamydia Trachomatis Infection

COMPLETED NA

Clinical Utility of Rapid CT/NG Testing in the ED

NCT02200224

Sexually Transmitted Diseases

COMPLETED NA

Chlamydia Trachomatis Immunology and Vaccinology Study

NCT01150747

Chlamydia

COMPLETED

Immunopathogenesis of Chlamydia

NCT00607659

CHLAMYDIA INFECTIONS

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this research project, the study aims to assess a screening strategy (early screening and treatment of Ct genital infection in young women to prevent complications) that may be implemented in the future if proved efficient 7 centers are involved in the enrollment (university health services), and 4 centers will participate in the study within the frame of the follow-up and final visit (hospital gynaecology departments).

Participants included will have to perform 4 self-taken vaginal samples linked to four online corresponding questionnaires, at different timeframes 6-month apart to each other (M0, M6, M12, M18). The first sampling (M0) will be performed at the university health service, this self-taken sampling could also be performed at home later in case of menstruation; the others (M6, M12, M18) will be performed at home (or at the university if problem of sampling kits receiving at home).

Participants will be randomly assigned to one of the two following arms:

* in the non-intervention arm, participants will follow current guidelines of Ct screening (i.e. opportunistic screening only in STI clinics for women aged less than 25 years old), and their samples will be tested for Ct at M18 by the NRC;
* in the intervention arm, analyses for Ct will be carried out immediately by the NRC.

A final visit with a hospital gynecologist is planned for all participants between M18 and M24 and aims at providing an extensive clinical examination to seek for potential signs of pelvic inflammatory disease and to treat participants if needed.

Based on all data collected on the electronic platform through questionnaires from the different visits, independent experts blinded on chlamydia status will assess PID status of all participants (no PID, probable PID, confirmed PID).

The duration of enrollment is planned for 36 months.

The duration of follow-up for each patient is 18 months to 24 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Genital Chlamydia Trachomatis Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

Testing for Ct infection immediately

Participants will perform self-taken vaginal samples.

The positive results for Ct will be examined and treated and their partner will also be informed to do so.

Group Type EXPERIMENTAL

Testing for Ct infection immediately

Intervention Type OTHER

Self-taken vaginal samples will be immediately tested for Ct infection at the National Reference Centre (CNR) at University of Bordeaux, using a commercially available CE marketed real-time PCR assay.

Control group

Testing for Ct infection at the end of the study

Group Type EXPERIMENTAL

Testing for Ct infection at the end of the study

Intervention Type OTHER

Self-taken vaginal samples will be tested for Ct infection at the end of the study (M18).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Testing for Ct infection immediately

Self-taken vaginal samples will be immediately tested for Ct infection at the National Reference Centre (CNR) at University of Bordeaux, using a commercially available CE marketed real-time PCR assay.

Intervention Type OTHER

Testing for Ct infection at the end of the study

Self-taken vaginal samples will be tested for Ct infection at the end of the study (M18).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* female students visiting the preventive medical centers of universities or the Ct screening test centers who participate in the study;
* participate in or will participate in the "i-Share" cohort;
* aged between 18 to 24 years,
* had prior sexual relations,
* written informed consent signed,
* affiliated to the social security bodies.